Literature DB >> 29806975

Leptin/osteopontin axis contributes to enhanced T helper 17 type responses in allergic rhinitis.

Wenlong Liu1, Qingxiang Zeng1, Lifeng Zhou1, Yan Li1, Yanqiu Chen1, RenZhong Luo1.   

Abstract

BACKGROUND: Recent studies suggest that T helper 17 (Th17) cell subset, a distinct pro-inflammatory CD4 +  T cell lineage, may play an important role in the pathophysiology of allergic rhinitis (AR). However, the regulation of Th17 response in allergic disease is not well characterized.
METHODS: Thirty AR and 30 healthy children were enrolled. Serum leptin and OPN levels were measured, and their correlation with IL-17 expression was analyzed using enzyme-linked immunosorbent assay (ELISA). Th17 cell differentiation and cytokine production in peripheral blood mononuclear cell (PBMCs) stimulated by leptin and OPN and related inhibitors were analyzed by ELISA. AR mice models were also established to verify the effect of leptin and OPN on Th17 cell regulation. Immunoprecipitation was performed to explore the interaction between OPN and leptin in Th17 cells.
RESULTS: Our results showed that elevated serum leptin and OPN in AR children were correlated with serum IL-17 level (r = .53, P < .01). The recombinant leptin and OPN enhanced Th17 responses from PBMCs synergistically through nuclear factor κB (NF-κB), mitogen-activated protein kinase (MAPK), and c-Jun N-terminal kinase (JNK) pathway and β3 integrin receptor. The AR mice showed as more severe Th17 responses and symptoms compared with control mice. Immunoprecipitation showed that OPN and leptin may interact with each other directly, and this process may be mediated by β3 integrin.
CONCLUSIONS: Our data provide evidence that upregulation of leptin and OPN promotes Th17 responses in AR, and this process may be achieved through NF-κB, MAPK, and JNK pathway and β3 integrin.
© 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  IL-17; Th17; allergic rhinitis; leptin; osteopontin

Mesh:

Substances:

Year:  2018        PMID: 29806975     DOI: 10.1111/pai.12926

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  5 in total

1.  MicroRNA-375-mediated regulation of ILC2 cells through TSLP in allergic rhinitis.

Authors:  Xi Luo; Qingxiang Zeng; Shengbao Yan; Wenlong Liu; Renzhong Luo
Journal:  World Allergy Organ J       Date:  2020-08-09       Impact factor: 4.084

2.  The changes of clinical and histological characteristics of chronic rhinosinusitis in 18 years: Was there an inflammatory pattern shift in southern China?

Authors:  Xin Luo; Zhaofeng Xu; Kejun Zuo; Jie Deng; Wenxiang Gao; Lijie Jiang; Lei Xu; Zhaoqi Huang; Jianbo Shi; Yinyan Lai
Journal:  World Allergy Organ J       Date:  2021-04-16       Impact factor: 4.084

3.  Mechanism of allergic rhinitis treated by Centipeda minima from different geographic areas.

Authors:  Yanzhuo Jia; Junbo Zou; Yao Wang; Xiaofei Zhang; Yajun Shi; Yulin Liang; Dongyan Guo; Ming Yang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

4.  Leptin Regulated ILC2 Cell through the PI3K/AKT Pathway in Allergic Rhinitis.

Authors:  Qingxiang Zeng; Xi Luo; Yiquan Tang; Wenlong Liu; Renzhong Luo
Journal:  Mediators Inflamm       Date:  2020-03-07       Impact factor: 4.711

5.  Leptin Promoted IL-17 Production from ILC2s in Allergic Rhinitis.

Authors:  Yanhui Wen; Qingxiang Zeng; Xi Luo; Renqiang Ma; Yiquan Tang; Wenlong Liu
Journal:  Mediators Inflamm       Date:  2020-09-09       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.